| scholarly article | Q13442814 |
| P2093 | author name string | Richard J Barohn | |
| Jeffrey M Statland | |||
| P2860 | cites work | A sodium channel defect in hyperkalemic periodic paralysis: potassium-induced failure of inactivation | Q67915164 |
| The exercise test in periodic paralysis | Q69670928 | ||
| Myotonia fluctuans. A third type of muscle sodium channel disease | Q72855968 | ||
| Autosomal dominant monosymptomatic myotonia permanens | Q79873682 | ||
| Treatment for periodic paralysis | Q24242271 | ||
| Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome | Q24291252 | ||
| The skeletal muscle chloride channel in dominant and recessive human myotonia | Q24293083 | ||
| Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis | Q24295040 | ||
| Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus | Q24678587 | ||
| Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene | Q28242463 | ||
| Pathomechanisms in channelopathies of skeletal muscle and brain | Q28246271 | ||
| Population frequencies of inherited neuromuscular diseases—A world survey | Q28266298 | ||
| Evoked response testing in myotonic syndromes | Q28270167 | ||
| Correlating phenotype and genotype in the periodic paralyses | Q28292375 | ||
| Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies | Q30498413 | ||
| The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. | Q33570009 | ||
| Myotonia congenita in northern Finland: an epidemiological and genetic study | Q33680517 | ||
| Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre. | Q33807683 | ||
| Periodic paralysis | Q34015907 | ||
| Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita). | Q34327027 | ||
| A sodium channel knockin mutant (NaV1.4-R669H) mouse model of hypokalemic periodic paralysis | Q35370222 | ||
| Measuring quality of life impairment in skeletal muscle channelopathies. | Q36382734 | ||
| A calcium channel mutant mouse model of hypokalemic periodic paralysis | Q36498120 | ||
| Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial | Q36587149 | ||
| Bumetanide prevents transient decreases in muscle force in murine hypokalemic periodic paralysis. | Q36870057 | ||
| Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias | Q36948037 | ||
| Non-dystrophic myotonia: prospective study of objective and patient reported outcomes | Q36953843 | ||
| Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions. | Q36968772 | ||
| Voltage-sensor mutations in channelopathies of skeletal muscle | Q37692699 | ||
| Hereditary nondystrophic myotonias and periodic paralyses | Q40935259 | ||
| Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene | Q41135926 | ||
| Severe neonatal episodic laryngospasm due to de novo SCN4A mutations: a new treatable disorder | Q42936044 | ||
| Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders | Q44406250 | ||
| Propagation disturbance of motor unit action potentials during transient paresis in generalized myotonia: a high-density surface EMG study | Q49076358 | ||
| Acetazolamide-responsive myotonia congenita. | Q51630181 | ||
| Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. | Q51739604 | ||
| Electromyography guides toward subgroups of mutations in muscle channelopathies. | Q64945413 | ||
| P433 | issue | 6 Muscle Disease | |
| P304 | page(s) | 1598-1614 | |
| P577 | publication date | 2013-12-01 | |
| P1433 | published in | Continuum : lifelong learning in neurology | Q26867022 |
| P1476 | title | Muscle channelopathies: the nondystrophic myotonias and periodic paralyses | |
| P478 | volume | 19 |
| Q41115388 | Bodybuilding championships and myotonia congenita |
| Q38760046 | Dichlorphenamide: A Review in Primary Periodic Paralyses |
| Q36130245 | Normal muscle structure, growth, development, and regeneration |
| Q45957826 | Review of the Diagnosis and Treatment of Periodic Paralysis. |
| Q57811084 | Skeletal Muscle Channelopathies |
Search more.